Automated method for detecting increases in frequency of spontaneous adverse event reports over time

Journal of Biopharmaceutical Statistics

Volumn 23, Issue 1, 2013, Pages 161-177

  Dumouchel, William ^a   Yuen, Nancy ^b   Payvandi, Nassrin ^b   Booth, Wendy ^b   Rut, Andrew ^b   Fram, David ^c  

^a Oracle Health Sciences   (United States)

^b GLAXOSMITHKLINE   (United States)

^c Commonwealth Informatics Inc ^*  (United States)

Author keywords

Increased frequency; Pharmacovigilance; Spontaneous adverse events

Indexed keywords

ACICLOVIR; CEFUROXIME AXETIL; DIGOXIN; MIVACURIUM; NABUMETONE; ONDANSETRON; PARACETAMOL; SALBUTAMOL; SUMATRIPTAN; THYROXINE;

ALGORITHM; ARTICLE; AUTOMATION; CALCULATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; MULTIPLE REGRESSION; PREDICTIVE VALUE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SIMULATION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AUTOMATIC DATA PROCESSING; HUMANS; PHARMACEUTICAL PREPARATIONS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84873283546     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543406.2013.736809     Document Type: Article

References (15)

1. Almenoff, J. S., Powell, G., Schaaf, R., Fram, D., Fitzpatrick, J. M., Pendleton, A., Payvandi, N., Yuen, N. (2007). Online signal management: A systems-based approach that delivers new analytical capabilities and operational efficiency to the practice of Pharmacovigilance. Drug Information Journal 41:779-789. (Pubitemid 350133292)
2. Bate, A., Lindquist, M., Edwards, I. R., Orre, R. (2002). A data mining approach for signal detection and analysis. Drug Safety 25:393-397. (Pubitemid 34729137)
3. Chambers, J., Cleveland, W., Kleiner, B., Tukey, J. (1983). Graphical Methods for Data Analysis. Belmont, CA: Wadsworth.
4. Clark, J. A., Klincewicz, S. L., Stang, P. E. (2001). Spontaneous adverse event signaling methods: Classification and use with health care treatment products. Epidemiology Reviews 23(2):191-210. (Pubitemid 34074109)
5. DuMouchel, W., Pregibon, D. (2001). Empirical Bayes screening for multi-item associations. In: 7th ACM SigKDD International Conference on Knowledge Discovery & Data Mining. San Francisco: ACM Press.
6. Evans, S., Waller, P. C., Davis, S. (2001). Use of PRR for signal generation from spontaneous ADR reports. Pharmacoepidemiology and Drug Safety 10:483-486.
7. Food and Drug Administration. (1992). Guideline for postmarketing reporting of adverse drug experiences. Federal Register 57(248):61437.
8. Food and Drug Administration. (2008). Information on Adverse Event Reports and Heparin. Available at http://www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ucm112669.htm (accessed September 8, 2011).
9. Hillson, E. M., Reeves, J. H., McMillan, C. A. (1998). A statistical signaling model for use in surveillance of adverse drug reaction data. Journal of Applied Statistics 25:23-40. (Pubitemid 128633848)
10. Lao, C. S., Kessler, L. G., Gross, T. P. (1998). Proposed statistical methods for signal detection of adverse medical device events. Drug Information Journal 32:183-191. (Pubitemid 28114950)
11. Payvandi, N. (2010). Overall performance of a signal management system - What does the data tell us. Drug Information Association Euro Meeting. March 8-10, Monaco.
12. Praus, M., Schindel, F., Fescharek, R., Schwarz, S. (1993). Alert systems for post-marketing surveillance of adverse drug reactions. Statistics in Medicine 12:2383-2393. (Pubitemid 24007157)
13. Ryan, P. B., Powell, G. E., Pattishall, E. N. (2008). Observational screening: A novel approach to analyzing observational data to supplement post-approval signal detection. Pharmacoepidemiol and Drug Safety 17:S179 (Abstract 408).
14. Sonesson, C., Bock, D. (2003). A review and discussion of prospective statistical surveillance in public health. Journal of Royal Statistical Society A 166(1):5-21. (Pubitemid 41685369)
15. Stroup, D. F., Thacker, S. B. (1993). A Bayesian approach to the detection of aberrations in public health surveillance data. Epidemiology 4:435-443. (Pubitemid 23261376)